Added value of randomized biopsy to mpMRI-targeted biopsy of the prostate in a contemporary cohort.
Prostate cancer
added value
multiparametric magnetic resonance imaging-targeted biopsy
overdiagnosis
systematic randomized biopsy
Journal
BJU international
ISSN: 1464-410X
Titre abrégé: BJU Int
Pays: England
ID NLM: 100886721
Informations de publication
Date de publication:
07 Dec 2023
07 Dec 2023
Historique:
medline:
7
12
2023
pubmed:
7
12
2023
entrez:
7
12
2023
Statut:
aheadofprint
Résumé
To assess the added value of concurrent systematic randomized ultrasound-guided biopsy (SBx) to multiparametric magnetic resonance imaging (mpMRI)-targeted biopsy and the additional rate of overdiagnosis of clinically insignificant prostate cancer (ciPCa) by SBx in a large contemporary, real-world cohort.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
This article is protected by copyright. All rights reserved.